Georges JOURDI

Has grant

Clinical Pathologist & Ass. Prof. (MCU-PH)

Assistance Publique - Hôpitaux de Paris

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Étude translationnelle préclinique et clinique de la contribution du facteur neurotrophique dérivé du cerveau (Brain-Derived-Neurotrophic Factor) à l'hémostase et à la pathologie cardiovasculaire

Open Date: 2020-11-01

Close Date: 2022-11-01

Grant: Close

A Novel Universal Antidote To Non Vitamin K Anticoagulant Drugs

Open Date: 2018-07-01

Close Date: 2019-07-01

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Eric Solary

Full-Professor in hematology

Sorbonne Université Faculté de Médecine

FRANCE

View details

Virginie Siguret

Professor

Université Paris Descartes

FRANCE

View details

frank griscelli

FRANCE

View details

Chloe James

Professor

University of Bordeaux

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Georges JOURDI

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches

Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers

GFHT proposals on the practical use of argatroban — With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)

Induced forms of α2-macroglobulin neutralize heparin and direct oral anticoagulant effects

Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome

Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases

Lupus Anticoagulant Single Positivity During the Acute Phase of COVID‐19 Is Not Associated With Venous Thromboembolism or In‐Hospital Mortality

High D-dimer plasma concentration in systemic sclerosis patients: Prevalence and association with vascular complications

A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter

Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality

Collaborators (4)

Eric Solary

Virginie Siguret

frank griscelli

Chloe James

Make your next move.